HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Romei Selected Research

Calcitonin (Calcitonin, Eel)

1/2021Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid Tumors.
11/2020Polymorphisms Within the RET Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma.
1/2019Fifty Years After the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent Cases.
9/2015Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.
1/2014Medullary thyroid carcinoma in children.
9/2013Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.
3/2013Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association.
1/2013Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.
2/2012The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.
3/2011CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Romei Research Topics

Disease

18Neoplasms (Cancer)
01/2022 - 02/2003
15Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 02/2003
7medullary Thyroid cancer
01/2022 - 01/2004
5Papillary Thyroid Cancer
02/2021 - 04/2005
3Thyroid Nodule (Nodule, Thyroid)
01/2019 - 03/2013
2Carcinogenesis
10/2021 - 02/2021
2Anaplastic Thyroid Carcinoma
02/2021 - 11/2017
2Thyroid Diseases (Thyroid Disease)
12/2016 - 01/2004
2Nodular Goiter
03/2013 - 11/2004
2Ischemia
10/2011 - 08/2010
2Neoplasm Metastasis (Metastasis)
03/2011 - 10/2008
1Follicular Adenocarcinoma
02/2021
1Pheochromocytoma
01/2019
1Renal Cell Carcinoma (Grawitz Tumor)
03/2016
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
06/2015
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
06/2015
1Shock
06/2015
1Overweight
06/2014
1Genetic Predisposition to Disease (Genetic Predisposition)
10/2013
1Disease Progression
09/2013
1Epilepsy (Aura)
10/2011
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
03/2011
1Struma Ovarii
12/2005
1Thyrotoxicosis
12/2005
1Graves Disease (Basedow Disease)
11/2004
1Goiter
11/2004
1Adenoma (Adenomas)
05/2004
1Carcinoma (Carcinomatosis)
05/2004
1Testicular Neoplasms (Testicular Cancer)
02/2003

Drug/Important Bio-Agent (IBA)

12Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2021 - 01/2004
5Biological ProductsIBA
02/2021 - 11/2004
4Messenger RNA (mRNA)IBA
10/2021 - 02/2003
4Protein Isoforms (Isoforms)IBA
10/2021 - 09/2008
3Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2013
3AntigensIBA
09/2015 - 02/2003
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2011
2prolinedithiocarbamate (PDTC)IBA
02/2021 - 06/2018
2Tumor Biomarkers (Tumor Markers)IBA
03/2016 - 09/2013
2Proteins (Proteins, Gene)FDA Link
09/2015 - 04/2005
2CarbohydratesIBA
09/2015 - 09/2013
2Carcinoembryonic AntigenIBA
09/2015 - 09/2013
2Codon (Codons)IBA
06/2015 - 12/2011
2Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2011 - 08/2010
2NucleotidesIBA
03/2011 - 05/2004
1selpercatinibIBA
01/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
02/2021
1RacivirIBA
02/2021
1Capsules (Microcapsules)IBA
01/2021
1Galectin 3 (LGALS3)IBA
01/2021
1vandetanib (ZD6474)IBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2018
1Circulating Tumor DNAIBA
01/2018
1Hormones (Hormone)IBA
12/2016
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
12/2016
1SuspensionsIBA
03/2016
1NestinIBA
03/2016
1Cadherins (E-Cadherin)IBA
03/2016
1ChromograninsIBA
09/2015
1ORALIT (ORS)IBA
06/2014
1Proline (L-Proline)FDA Link
12/2011
1Genetic Markers (Genetic Marker)IBA
12/2011
1Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2011
1SodiumIBA
08/2010
1CalciumIBA
08/2010
1gamma-Aminobutyric Acid (GABA)IBA
08/2010
1IonsIBA
08/2010
1PotassiumIBA
08/2010
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2008
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
09/2008
1Glucose (Dextrose)FDA LinkGeneric
09/2008
1sodium-iodide symporter (sodium iodide symporter)IBA
06/2008
1ThyroglobulinFDA Link
12/2005
1Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2005
1retinoic acid receptor betaIBA
04/2005
1RNA (Ribonucleic Acid)IBA
04/2005
1IodineIBA
04/2005
1Pentagastrin (Peptavlon)FDA Link
11/2004
1AdenineFDA LinkGeneric
05/2004
1ThymineIBA
05/2004
1AntibodiesIBA
02/2003

Therapy/Procedure

2Therapeutics
11/2017 - 04/2005
1Drug Therapy (Chemotherapy)
04/2005
1Radiotherapy
04/2005
1Thyroidectomy
11/2004
1Immunotherapy
02/2003